Wikidata

(Q66031911)

English

A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
A Treatment Protocol For Patients With Gastrointestinal Stromal Tumor Who Are Ineligible For Participation In Other SU011248 Protocols And Are Refractory To Or Intolerant Of Imatinib Mesylate (English)
0 references
country
Argentina
0 references
Australia
0 references
Austria
0 references
Belgium
0 references
Canada
0 references
Chile
0 references
Colombia
0 references
Czech Republic
0 references
Denmark
0 references
Finland
0 references
France
0 references
Germany
0 references
Greece
0 references
Hungary
0 references
India
0 references
Israel
0 references
Italy
0 references
Mexico
0 references
Netherlands
0 references
Norway
0 references
Poland
0 references
Singapore
0 references
Slovakia
0 references
Spain
0 references
Sweden
0 references
Switzerland
0 references
Taiwan
0 references
Thailand
0 references
Turkey
0 references
United Kingdom
0 references
Venezuela
0 references
start time
September 2004
0 references
end time
October 2011
0 references
research site
Pfizer
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q66031911&oldid=2238099229"